(Q40506327)

21 September 2017

title

Screening-detected breast carcinoma in a patient with Cowden syndrome (English)

1 reference

21 September 2017

4

Bertone E

1 reference

21 September 2017

Baù MG

1

1 reference

21 September 2017

Arisio R

series ordinal

2

1 reference

21 September 2017

Cristini G

series ordinal

3

1 reference

21 September 2017

Campogrande M

series ordinal

5

1 reference

21 September 2017

publication date

1 June 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

13

1 reference

21 September 2017

issue

3

1 reference

21 September 2017

page(s)

239-241

1 reference

Role of PTEN, a lipid phosphatase upstream effector of protein kinase B, in epithelial thyroid carcinogenesis

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900168-1

7 January 2021

The Cowden syndrome: a clinical and genetic study in 21 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900168-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900168-1

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900168-1

1 reference

7 January 2021

Will the real Cowden syndrome please stand up: revised diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900168-1

7 January 2021

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900168-1

7 January 2021

Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900168-1

7 January 2021

Reduced expression of PTEN correlates with breast cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900168-1

7 January 2021

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900168-1

7 January 2021

Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2803%2900168-1

7 January 2021

10.1016/S0960-9776(03)00168-1

Identifiers

DOI

1 reference

21 September 2017

1 reference